Astrazeneca (AZN) Exceeds Market Returns: Some Facts to Consider

Astrazeneca (AZN) closed at $158.61, up 1.33%, outperforming the S&P 500. The pharmaceutical company is expected to report earnings on October 30, 2026, with predicted EPS of $2.16 (down 9.24% YoY) and revenue of $16.07 billion (up 5.82% YoY). AZN holds a Zacks Rank #3 (Hold) with a Forward P/E of 16.71, trading at a discount to its industry average of 22.46.